385 related articles for article (PubMed ID: 34360768)
81. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
[TBL] [Abstract][Full Text] [Related]
82. Predictive value of pretreatment inflammation-based prognostic scores (neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio) for invasive bladder carcinoma.
Lee SM; Russell A; Hellawell G
Korean J Urol; 2015 Nov; 56(11):749-55. PubMed ID: 26568792
[TBL] [Abstract][Full Text] [Related]
83. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
84. [Effects of Preoperative Immune and Nutritional Indices on the Prognosis of pStage Ⅱ and Ⅲ Colorectal Cancer].
Nakata Y; Furuya S; Takiguchi K; Ashizawa N; Shimizu H; Akaike H; Hosomura N; Kawaguchi Y; Amemiya H; Sudo M; Kawaida H; Inoue S; Kono H; Ichikawa D
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2389-2391. PubMed ID: 32156941
[TBL] [Abstract][Full Text] [Related]
85. THE ROLE OF COMPLETE BLOOD COUNT PARAMETERS IN PATIENTS WITH COLORECTAL CANCER.
Solak Mekić M; Pedišić I; Šobat H; Vučićević Boras V; Kirac I; Štefančić L; Šekerija M; Vrdoljak B; Vrdoljak DV
Acta Clin Croat; 2018 Dec; 57(4):624-629. PubMed ID: 31168198
[TBL] [Abstract][Full Text] [Related]
86. Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.
Shimura T; Shibata M; Gonda K; Hayase S; Sakamoto W; Okayama H; Fujita S; Saito M; Momma T; Ohki S; Kono K
Fukushima J Med Sci; 2018 Aug; 64(2):64-72. PubMed ID: 30012939
[TBL] [Abstract][Full Text] [Related]
87. A novel systematic inflammation related index is prognostic in curatively resected non-metastatic colorectal cancer.
Hong T; Shen D; Chen X; Cai D; Wu X; Hua D
Am J Surg; 2018 Sep; 216(3):450-457. PubMed ID: 28743381
[TBL] [Abstract][Full Text] [Related]
88. Prognostic Inflammation Score in Surgical Patients with Colorectal Cancer.
Seong MK
J Korean Med Sci; 2015 Dec; 30(12):1793-9. PubMed ID: 26713054
[TBL] [Abstract][Full Text] [Related]
89. Systemic inflammatory markers as prognostic factors in stage IIA colorectal cancer.
Park BK; Park JW; Han EC; Ryoo SB; Han SW; Kim TY; Chie EK; Jeong SY; Park KJ
J Surg Oncol; 2016 Aug; 114(2):216-21. PubMed ID: 27222402
[TBL] [Abstract][Full Text] [Related]
90. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: Systematic review and meta-analysis.
Dolan RD; McSorley ST; Horgan PG; Laird B; McMillan DC
Crit Rev Oncol Hematol; 2017 Aug; 116():134-146. PubMed ID: 28693795
[TBL] [Abstract][Full Text] [Related]
91. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
[TBL] [Abstract][Full Text] [Related]
92. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract][Full Text] [Related]
93. Lymphocyte-to-monocyte ratio effectively predicts survival outcome of patients with obstructive colorectal cancer.
Chen XQ; Xue CR; Hou P; Lin BQ; Zhang JR
World J Gastroenterol; 2019 Sep; 25(33):4970-4984. PubMed ID: 31543687
[TBL] [Abstract][Full Text] [Related]
94. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer.
Walsh SR; Cook EJ; Goulder F; Justin TA; Keeling NJ
J Surg Oncol; 2005 Sep; 91(3):181-4. PubMed ID: 16118772
[TBL] [Abstract][Full Text] [Related]
95. A novel prognostic score model based on combining systemic and hepatic inflammation markers in the prognosis of HBV-associated hepatocellular carcinoma patients.
Zhang T; Liu Z; Zhao X; Mao Z; Bai L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2246-2255. PubMed ID: 31169437
[No Abstract] [Full Text] [Related]
96. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
97. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
Qi Q; Geng Y; Sun M; Wang P; Chen Z
Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
[TBL] [Abstract][Full Text] [Related]
98. Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms?
Giannetta E; La Salvia A; Rizza L; Muscogiuri G; Campione S; Pozza C; Colao AAL; Faggiano A
Front Endocrinol (Lausanne); 2021; 12():672499. PubMed ID: 34367064
[TBL] [Abstract][Full Text] [Related]
99. Cumulative perioperative lymphocyte/C-reactive protein ratio as a predictor of the long-term outcomes of patients with colorectal cancer.
Okugawa Y; Toiyama Y; Fujikawa H; Kawamura M; Yasuda H; Yokoe T; Mochiki I; Okita Y; Ohi M; Nakatani K
Surg Today; 2021 Dec; 51(12):1906-1917. PubMed ID: 33954875
[TBL] [Abstract][Full Text] [Related]
100. The Pattern of Calculated Inflammation Ratios as Prognostic Values in Patients with Colorectal Cancer.
Ciocan A; Bolboacă SD; Drugan C; Ciocan RA; Graur F; Al Hajjar N
Comb Chem High Throughput Screen; 2021; 24(9):1428-1435. PubMed ID: 33081678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
